259 related articles for article (PubMed ID: 25611244)
1. α-Hemoglobin-stabilizing Protein: An Effective Marker for Erythroid Precursors in Bone Marrow Biopsy Specimens.
Yu H; Pinkus JL; Pinkus GS
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):51-6. PubMed ID: 25611244
[TBL] [Abstract][Full Text] [Related]
2. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens.
Marsee DK; Pinkus GS; Yu H
Am J Clin Pathol; 2010 Sep; 134(3):429-35. PubMed ID: 20716799
[TBL] [Abstract][Full Text] [Related]
3. α-Hemoglobin-stabilizing protein is a sensitive and specific marker of erythroid precursors.
Raess PW; Paessler ME; Bagg A; Weiss MJ; Choi JK
Am J Surg Pathol; 2012 Oct; 36(10):1538-47. PubMed ID: 22982896
[TBL] [Abstract][Full Text] [Related]
4. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A.
Dong HY; Wilkes S; Yang H
Am J Surg Pathol; 2011 May; 35(5):723-32. PubMed ID: 21415701
[TBL] [Abstract][Full Text] [Related]
5. Role of CD71 in acute leukemia- An immunophenotypic marker for erythroid lineage or proliferation?
Acharya S; Kala PS
Indian J Pathol Microbiol; 2019; 62(3):418-422. PubMed ID: 31361230
[TBL] [Abstract][Full Text] [Related]
6. Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia.
Liu Q; Wang M; Hu Y; Xing H; Chen X; Zhang Y; Zhu P
Leuk Lymphoma; 2014 Apr; 55(4):892-8. PubMed ID: 23962073
[TBL] [Abstract][Full Text] [Related]
7. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
8. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
Lee WY; Weinberg OK; Pinkus GS
Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase: a specific marker for myeloid cells in paraffin sections.
Pinkus GS; Pinkus JL
Mod Pathol; 1991 Nov; 4(6):733-41. PubMed ID: 1724087
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD71 antibody immunohistochemistry in the diagnosis of acute myeloid leukemia, subtype acute erythroid leukemia with erythroid dominance (AML M6-Er), in a retrovirus-negative cat.
Suzuki S; Ogino N; Mitsui I; Ito H; Kariya T
J Vet Diagn Invest; 2021 Jan; 33(1):87-94. PubMed ID: 33225861
[TBL] [Abstract][Full Text] [Related]
11. Expression of alpha-hemoglobin stabilizing protein and cellular prion protein in a subclone of murine erythroleukemia cell line MEL.
Otsuka Y; Ito D; Katsuoka K; Arashiki N; Komatsu T; Inaba M
Jpn J Vet Res; 2008 Aug; 56(2):75-84. PubMed ID: 18828445
[TBL] [Abstract][Full Text] [Related]
12. An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis.
Yu X; Kong Y; Dore LC; Abdulmalik O; Katein AM; Zhou S; Choi JK; Gell D; Mackay JP; Gow AJ; Weiss MJ
J Clin Invest; 2007 Jul; 117(7):1856-65. PubMed ID: 17607360
[TBL] [Abstract][Full Text] [Related]
13. GATA-1 and Oct-1 are required for expression of the human alpha-hemoglobin-stabilizing protein gene.
Gallagher PG; Liem RI; Wong E; Weiss MJ; Bodine DM
J Biol Chem; 2005 Nov; 280(47):39016-23. PubMed ID: 16186125
[TBL] [Abstract][Full Text] [Related]
14. Transgenic human alpha-hemoglobin stabilizing protein could partially relieve betaIVS-2-654-thalassemia syndrome in model mice.
Wang B; Fang Y; Guo X; Ren Z; Zhang J
Hum Gene Ther; 2010 Feb; 21(2):149-56. PubMed ID: 20063986
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections.
Pellegrini W; Facchetti F; Marocolo D; Salvi L; Capucci A; Tironi A; Rossi G
Histopathology; 1995 Nov; 27(5):397-405. PubMed ID: 8575729
[TBL] [Abstract][Full Text] [Related]
16. α-Hemoglobin stabilizing protein: a modulating factor in thalassemias?
Wajcman H; Vasseur C; Pissard S; Baudin-Creuza V
Hemoglobin; 2011; 35(5-6):463-8. PubMed ID: 21950764
[TBL] [Abstract][Full Text] [Related]
17. GLUT1 Immunohistochemistry Is a Highly Sensitive and Relatively Specific Marker for Erythroid Lineage in Benign and Malignant Hematopoietic Tissues.
Kaumeyer BA; Fidai SS; Thakral B; Wang SA; Arber DA; Cheng JX; Gurbuxani S; Venkataraman G
Am J Clin Pathol; 2022 Aug; 158(2):228-234. PubMed ID: 35311938
[TBL] [Abstract][Full Text] [Related]
18. DRAQ5-based, no-lyse, no-wash bone marrow aspirate evaluation by flow cytometry.
Allan RW; Ansari-Lari MA; Jordan S
Am J Clin Pathol; 2008 May; 129(5):706-13. PubMed ID: 18426729
[TBL] [Abstract][Full Text] [Related]
19. [Effects of yisui shengxue granules on expressions of alpha-hemoglobin stabilizing protein and erythroid transcription factor GATA-1 mRNAs in bone marrow of patients with beta-thalassemia].
Liu YM; Wu ZK; Chai LM; Zhang XH
Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):247-50. PubMed ID: 16696909
[TBL] [Abstract][Full Text] [Related]
20. HBME-1 is expressed by erythroid precursors in early maturation stage and can be a valuable tool for evaluation of dyserythropoiesis in bone marrow core biopsy specimens.
Arana R; Lusina D; Braun T; Letestu R; Gardin C; Martin A
J Clin Pathol; 2016 Oct; 69(10):933-7. PubMed ID: 27484914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
